Cargando…

siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy

Detalles Bibliográficos
Autores principales:	Hu, Bo, Huang, Yuanyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148020/ https://www.ncbi.nlm.nih.gov/pubmed/37128279 http://dx.doi.org/10.1016/j.omtn.2023.03.020

Ejemplares similares

Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020)

Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
por: Wang, Andrew Z.
Publicado: (2014)

Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys
por: Wang, Jue, et al.
Publicado: (2022)

siRNA goes after diseases of the bone
por: Coles, Andrew H.
Publicado: (2023)

Bridging siRNA strands for better function
por: Rossi, John J.
Publicado: (2023)

Toward learning the rules that predict siRNA efficacy
por: Bofill-De Ros, Xavier
Publicado: (2023)

Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection
por: Shubhra, Quazi T.H., et al.
Publicado: (2023)

Inclisiran: a new generation of lipid-lowering siRNA therapeutic
por: Zhang, Yanzhen, et al.
Publicado: (2023)

Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment
por: Guo, Shuai, et al.
Publicado: (2021)

RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study
por: Watts, Gerald F., et al.
Publicado: (2023)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles
por: Hanafy, Mahmoud S., et al.
Publicado: (2023)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

Rolling Circle Transcription of Tandem siRNA to Generate Spherulitic RNA Nanoparticles for Cell Entry
por: Guo, Peixuan
Publicado: (2012)

Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA
por: Ge, Xuemei, et al.
Publicado: (2021)

Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
por: Butowska, Kamila, et al.
Publicado: (2023)

Systemic Administration of siRNA via cRGD-containing Peptide
por: Huang, Yuanyu, et al.
Publicado: (2015)

Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
por: Zatsepin, Timofei S, et al.
Publicado: (2016)

siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication
por: Kok, Kin-Hang, et al.
Publicado: (2009)

Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
por: Mainini, Francesco, et al.
Publicado: (2020)

Spotlight Commentary: What's new in lipid‐lowering pharmacology? Integrating basic and clinical research to improve patient outcomes
por: Penson, Peter E.
Publicado: (2020)

Pharmacokinetic Behaviors of Intravenously Administered siRNA in Glandular Tissues
por: Huang, Yuanyu, et al.
Publicado: (2016)

PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines
por: Zhang, Shuwei, et al.
Publicado: (2018)

The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy
por: Du, Lili, et al.
Publicado: (2017)

siRNA Targeting and Treatment of Gastrointestinal Diseases
por: Chevalier, Rachel
Publicado: (2019)

siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
por: Kalita, Tutu, et al.
Publicado: (2022)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery
por: Li, Yujing, et al.
Publicado: (2016)

Photochemical Internalization of siRNA for Cancer Therapy
por: Ali, Lamiaa Mohamed Ahmed, et al.
Publicado: (2022)

The iPSC Awakens ANGPTL3 in Tangier Disease
por: Lee, Man K.S., et al.
Publicado: (2017)

Red‐shifted optogenetics comes to the spotlight
por: Wang, Tianlu, et al.
Publicado: (2022)

Inhibition of retinal neovascularization by siRNA targeting VEGF(165)
por: Xia, Xiao-bo, et al.
Publicado: (2008)

Window of Opportunity: Targeting ANGPTL4 Improves Triglyceride Levels in Maternal Obesity During Pregnancy
por: Alejandro, Emilyn U., et al.
Publicado: (2020)

Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B
por: Huang, Yuanyu, et al.
Publicado: (2022)

Spotlight on… Janet K. Jansson
por: Jansson, Janet K.
Publicado: (2016)

Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery
por: Huang, Xueqin, et al.
Publicado: (2017)

High Efficiency Lipid-Based siRNA Transfection of Adipocytes in Suspension
por: Kilroy, Gail, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1n7ofo3r7ag70imn4cp9vkiojd